Kurnick NB. Autonomic hyperreflexia and its control in patients with spinal cord lesions. Ann Intern Med. 1956;44:678–86.

Article  CAS  PubMed  Google Scholar 

Faaborg PM, Christensen P, Krassioukov A, Laurberg S, Frandsen E, Krogh K. Autonomic dysreflexia during bowel evacuation procedures and bladder filling in subjects with spinal cord injury. Spinal Cord. 2014;52:494–8. https://doi.org/10.1038/sc.2014.45.

Article  CAS  PubMed  Google Scholar 

Krassioukov A, Warburton DE, Teasell R, Eng JJ. Spinal Cord Injury Rehabilitation Evidence Research Team A systematic review of the management of autonomic dysreflexia after spinal cord injury. Arch Phys Med Rehabil. 2009;90:682–95.

Article  PubMed  PubMed Central  Google Scholar 

Blackmer J. Rehabilitation medicine: 1. Autonomic dysreflexia. CMAJ 2020;169:931–5.

Google Scholar 

de Groat WC, Yoshimura N. Changes in afferent activity after spinal cord injury. Neurourol Urodyn. 2010;29:63–76.

Article  PubMed  PubMed Central  Google Scholar 

Giannantoni A, Di Stasi SM, Stephen RL, Navarra P, Scivoletto G, Mearini E, et al. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol. 2002;167:1710–4.

Article  CAS  PubMed  Google Scholar 

Igawa Y, Satoh T, Mizusawa H, Seki S, Kato H, Ishizuka O, et al. The role of capsaicin-sensitive afferents in autonomic dysreflexia in patients with spinal cord injury. BJU Int. 2003;91:637–41.

Article  CAS  PubMed  Google Scholar 

Holzer P, Bucsics A, Lembeck F. Distribution of capsaicin-sensitive nerve fibres containing immunoreactive substance P in cutaneous and visceral tissues of the rat. Neurosci Lett. 1982;31:253–7.

Article  CAS  PubMed  Google Scholar 

Shaker H, Wang Y, Loung D, Balbaa L, Fehlings MG, Hassouna MM. Role of C-afferent fibres in the mechanism of action of sacral nerve root neuromodulation in chronic spinal cord injury. BJU Int. 2000;85:905–10.

Article  CAS  PubMed  Google Scholar 

Green SA, Alon A, Ianus J, McNaughton KS, Tozzi CA, Reiss TF. Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence. J Urol. 2006;176:2535–40.

Article  CAS  PubMed  Google Scholar 

Frenkl TL, Zhu H, Reiss T, Seltzer O, Rosenberg E, Green S. A multicenter, double-blind, randomized, placebo-controlled trial of a neurokinin-1 receptor antagonist for overactive bladder. J Urol. 2010;184:616–22.

Article  CAS  PubMed  Google Scholar 

Teasell RW, Arnold JM, Krassioukov A, Delaney GA. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000;81:506–16.

Article  CAS  PubMed  Google Scholar 

Hou S, Duale H, Cameron AA, Abshire SM, Lyttle TS, Rabchevsky AG. Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection. J Comp Neurol. 2008;509:382–99.

Article  PubMed  PubMed Central  Google Scholar 

Llewellyn-Smith IJ, Martin CL, Minson JB, Pilowsky PM, Arnolda LF, Basbaum AI, et al. Neurokinin-1 receptor-immunoreactive sympathetic preganglionic neurons: target specificity and ultrastructure. Neuroscience. 1997;77:1137–49.

Article  CAS  PubMed  Google Scholar 

Cassam AK, Llewellyn-Smith IJ, Weaver LC. Catecholamine enzymes and neuropeptides are expressed in fibres and somata in the intermediate gray matter in chronic spinal rats. Neuroscience. 1997;78:829–41.

Article  CAS  PubMed  Google Scholar 

Klimaschewski L. Increased innervation of rat preganglionic sympathetic neurons by substance P containing nerve fibers in response to spinal cord injury. Neurosci Lett. 2001;307:73–76.

Article  CAS  PubMed  Google Scholar 

Rabchevsky AG, Patel SP, Duale H, Lyttle TS, O’Dell CR, Kitzman PH. Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury. Spinal Cord. 2012;49:99–105.

Article  Google Scholar 

Hou S, Blesch A, Lu P. A radio-telemetric system to monitor cardiovascular function in rats with spinal cord transection and embryonic neural stem cell grafts. J Vis Exp. 2014;92:e51914.

Google Scholar 

Rupniak NM, Carlson EJ, Shepheard S, Bentley G, Williams AR, Hill A, et al. Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608. Neuropharmacology. 2003;45:231–41.

Article  CAS  PubMed  Google Scholar 

Hutson PH, Patel S, Jay MT, Barton CL. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist. Eur J Pharm. 2004;484:57–64.

Article  CAS  Google Scholar 

Jung M, Calassi R, Maruani J, Barnouin MC, Souilhac J, Poncelet M, et al. Neuropharmacological characterization of SR 140333, a non-peptide antagonist of NK1 receptors. Neuropharmacology. 1994;33:167–79.

Article  CAS  PubMed  Google Scholar 

Lombet A, Spedding M. Differential effects of non-peptidic tachykinin receptor antagonists on Ca2 + channels. Eur J Pharm. 1994;267:113–5.

Article  CAS  Google Scholar 

Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE, et al. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology. 2002;27:371–9.

Article  CAS  PubMed  Google Scholar 

Smith G, Harrison S, Bowers J, Wiseman J, Birch P. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. Eur J Pharm. 1994;271:481–7.

Article  Google Scholar 

Brocco M, Dekeyne A, Mannoury la Cour C, Touzard M, Girardon S, Veiga S, et al. Cellular and behavioural profile of the novel selective neurokinin 1 receptor antagonist vestipitant: a comparison to other agents. Eur Neuropsychopharmacol. 2008;18:729–50.

Article  CAS  PubMed  Google Scholar 

Rupniak NM, Webb JK, Williams AR, Carlson E, Boyce S, Hill RG. Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils. Br J Pharm. 1995;116:1937–43.

Article  CAS  Google Scholar 

McLean S, Ganong A, Seymour PA, Snider RM, Desai MC, Rosen T, et al. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharm Exp Ther. 1993;267:472–9.

CAS  Google Scholar 

Gardner CJ, Armour DR, Beattie DT, Gale JD, Hawcock AB, Kilpatrick GJ, et al. GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity. Regul Pept. 1996;65:45–53.

Article  CAS  PubMed  Google Scholar 

Sharif H, Hou S. Autonomic dysreflexia: a cardiovascular disorder following spinal cord injury. Neural Regen Res. 2017;12:1390–1400.

Article  PubMed  PubMed Central  Google Scholar 

Bycroft J, Shergill IS, Choong EAL, Arya N, Shah PJR. Autonomic dysreflexia: a medical emergency. Postgrad Med J. 2005;81:232–5.

Article  CAS  PubMed  PubMed Central  Google Scholar